首页 > 最新文献

Neurobiology of Pain最新文献

英文 中文
Cerebral peak alpha frequency: Associations with chronic pain onset and pain modulation
Q2 Medicine Pub Date : 2025-02-28 DOI: 10.1016/j.ynpai.2025.100180
Felicitas A. Huber , Parker A. Kell , Joanna O. Shadlow , Jamie L. Rhudy
Chronic pain is highly prevalent in the U.S. and leads to myriad negative sequalae and suffering. One way to address chronic pain is to identify who is at risk and intervene prior to symptom onset. Research suggests resting peak alpha frequency (PAF), the speed of alpha oscillations at rest, is slower in healthy individuals with greater pain sensitivity and in chronic pain patients. Thus, slower PAF may denote chronic pain vulnerability. Other research has shown that individuals at higher risk of chronic pain exhibit disrupted pain modulation, i.e., less efficient pain inhibition and increased pain facilitation. Currently, the ability of PAF to predict chronic pain and its relation to pain modulation is under-researched. This investigation aimed to address this gap by characterizing associations between PAF, onset of chronic pain, and pain modulation. Using archival data from three independent studies, this investigation assessed whether slower PAF is associated with prospectively-determined chronic pain onset, decreased pain inhibition (i.e., impaired conditioned pain modulation, impaired erotica-induced pain inhibition), and increased pain facilitation (i.e., increased temporal summation of pain, augmented mutilation-induced pain facilitation). Results show that slower PAF was associated with greater facilitation of spinal (i.e., nociceptive flexion reflex) and supraspinal (i.e., N2 potential) nociception in response to unpleasant pictures (i.e., human injury images). This suggests that slower PAF is associated with threat-enhanced spinal and supraspinal nociception and may be relevant for chronic pain conditions with disrupted threat systems. Slower PAF was not associated with any other pain outcome, including prospectively determined chronic pain onset. However, chronic pain onset could only be assessed in one study with a mixed eyes open/eyes closed recording, limiting the significance of this finding.
{"title":"Cerebral peak alpha frequency: Associations with chronic pain onset and pain modulation","authors":"Felicitas A. Huber ,&nbsp;Parker A. Kell ,&nbsp;Joanna O. Shadlow ,&nbsp;Jamie L. Rhudy","doi":"10.1016/j.ynpai.2025.100180","DOIUrl":"10.1016/j.ynpai.2025.100180","url":null,"abstract":"<div><div>Chronic pain is highly prevalent in the U.S. and leads to myriad negative sequalae and suffering. One way to address chronic pain is to identify who is at risk and intervene prior to symptom onset. Research suggests resting peak alpha frequency (PAF), the speed of alpha oscillations at rest, is slower in healthy individuals with greater pain sensitivity and in chronic pain patients. Thus, slower PAF may denote chronic pain vulnerability. Other research has shown that individuals at higher risk of chronic pain exhibit disrupted pain modulation, i.e., less efficient pain inhibition and increased pain facilitation. Currently, the ability of PAF to predict chronic pain and its relation to pain modulation is under-researched. This investigation aimed to address this gap by characterizing associations between PAF, onset of chronic pain, and pain modulation. Using archival data from three independent studies, this investigation assessed whether slower PAF is associated with prospectively-determined chronic pain onset, decreased pain inhibition (i.e., impaired conditioned pain modulation, impaired erotica-induced pain inhibition), and increased pain facilitation (i.e., increased temporal summation of pain, augmented mutilation-induced pain facilitation). Results show that slower PAF was associated with greater facilitation of spinal (i.e., nociceptive flexion reflex) and supraspinal (i.e., N2 potential) nociception in response to unpleasant pictures (i.e., human injury images). This suggests that slower PAF is associated with threat-enhanced spinal and supraspinal nociception and may be relevant for chronic pain conditions with disrupted threat systems. Slower PAF was not associated with any other pain outcome, including prospectively determined chronic pain onset. However, chronic pain onset could only be assessed in one study with a mixed eyes open/eyes closed recording, limiting the significance of this finding.</div></div>","PeriodicalId":52177,"journal":{"name":"Neurobiology of Pain","volume":"18 ","pages":"Article 100180"},"PeriodicalIF":0.0,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143548952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The contribution of clock genes BMAL1 and PER2 in osteoarthritis-associated pain
Q2 Medicine Pub Date : 2025-01-01 DOI: 10.1016/j.ynpai.2024.100177
Erick J. Rodríguez-Palma , Santiago Loya-Lopez , Kyle Allen , Yenisel Cruz-Almeida , Rajesh Khanna
Joint pain is the primary symptom of osteoarthritis (OA) and the main motivator for patients to seek medical care. OA-related pain significantly restricts joint function and diminishes quality of life. Despite the availability of various pain-relieving medications for OA, current treatment strategies often fall short in delivering adequate pain relief. Furthermore, long-term use of pain medications for OA management is frequently linked with notable side effects and toxicities, suggesting the need to explore new potential targets to treat pain in OA patients. In this context, clock genes, particularly brain and muscle aryl hydrocarbon receptor nuclear translocator-like 1 (BMAL1) and period circadian protein homolog 2 (PER2), known for their role in circadian rhythms, represent promising opportunities for pharmacological interventions due to their involvement in both the development and maintenance of OA pain. While BMAL1 and PER2 have been extensively studied in neuropathic and inflammatory pain, their specific contributions to OA pain remain less clear, demanding further investigation. This narrative review aims to synthesize the relationship between OA pain and the BMAL1 and PER2 signaling pathways, ultimately exploring the potential therapeutic role of clock genes in addressing this challenging condition.
{"title":"The contribution of clock genes BMAL1 and PER2 in osteoarthritis-associated pain","authors":"Erick J. Rodríguez-Palma ,&nbsp;Santiago Loya-Lopez ,&nbsp;Kyle Allen ,&nbsp;Yenisel Cruz-Almeida ,&nbsp;Rajesh Khanna","doi":"10.1016/j.ynpai.2024.100177","DOIUrl":"10.1016/j.ynpai.2024.100177","url":null,"abstract":"<div><div>Joint pain is the primary symptom of osteoarthritis (OA) and the main motivator for patients to seek medical care. OA-related pain significantly restricts joint function and diminishes quality of life. Despite the availability of various pain-relieving medications for OA, current treatment strategies often fall short in delivering adequate pain relief. Furthermore, long-term use of pain medications for OA management is frequently linked with notable side effects and toxicities, suggesting the need to explore new potential targets to treat pain in OA patients. In this context, clock genes, particularly brain and muscle aryl hydrocarbon receptor nuclear translocator-like 1 (BMAL1) and period circadian protein homolog 2 (PER2), known for their role in circadian rhythms, represent promising opportunities for pharmacological interventions due to their involvement in both the development and maintenance of OA pain. While BMAL1 and PER2 have been extensively studied in neuropathic and inflammatory pain, their specific contributions to OA pain remain less clear, demanding further investigation. This narrative review aims to synthesize the relationship between OA pain and the BMAL1 and PER2 signaling pathways, ultimately exploring the potential therapeutic role of clock genes in addressing this challenging condition.</div></div>","PeriodicalId":52177,"journal":{"name":"Neurobiology of Pain","volume":"17 ","pages":"Article 100177"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11754085/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glial activation and nociceptive neuropeptide elevation associated with the development of chronic post-traumatic headache following repetitive blast exposure
Q2 Medicine Pub Date : 2025-01-01 DOI: 10.1016/j.ynpai.2024.100178
Amirah Wright , Susan F. Murphy , Pamela J. VandeVord
Chronic headaches and pain are prevalent in those who are exposure to blast events, yet there is a gap in fundamental data that identifies the pathological mechanism for the chronification of pain. Blast-related post-traumatic headaches (PTH) are understudied and chronic pain behaviors in preclinical models can be vital to help elucidate PTH mechanisms. The descending pain modulatory system controls pain perception and involves specific brain regions such as the cortex, thalamus, pons, and medulla. In this study, male rats were exposed to repeated blast events to induce traumatic brain injury (bTBI) and subsequently assessed for the development of PTH by testing for chronic pain behaviors and examining the neuropathology of the descending pain pathway. The results demonstrated that facial hypersensitivity developed as early as week two following bTBI and persisted throughout the study (12 weeks). Depressive-like behaviors were observed at 12 weeks following bTBI, and these behaviors were associated with neuropathologies such as microglia ramification and neuropeptide elevation (Calcitonin Gene-Related Peptide, CGRP; Substance P, SP). Overall, these findings support the hypothesis that bTBI causes the activation of microglia and elevation of neuropeptides, which contribute to the development of chronic PTH behaviors.
{"title":"Glial activation and nociceptive neuropeptide elevation associated with the development of chronic post-traumatic headache following repetitive blast exposure","authors":"Amirah Wright ,&nbsp;Susan F. Murphy ,&nbsp;Pamela J. VandeVord","doi":"10.1016/j.ynpai.2024.100178","DOIUrl":"10.1016/j.ynpai.2024.100178","url":null,"abstract":"<div><div>Chronic headaches and pain are prevalent in those who are exposure to blast events, yet there is a gap in fundamental data that identifies the pathological mechanism for the chronification of pain. Blast-related post-traumatic headaches (PTH) are understudied and chronic pain behaviors in preclinical models can be vital to help elucidate PTH mechanisms. The descending pain modulatory system controls pain perception and involves<!--> <!-->specific brain regions such as the cortex, thalamus, pons, and medulla. In this study, male rats were exposed to repeated blast events to induce traumatic brain injury (bTBI) and subsequently assessed for the development of PTH by testing for chronic pain behaviors and examining the neuropathology of the descending pain pathway. The results demonstrated that facial hypersensitivity developed as early as week two following bTBI and persisted throughout the study (12 weeks). Depressive-like behaviors were observed at 12 weeks following bTBI, and these behaviors were associated with neuropathologies such as microglia ramification and neuropeptide elevation (Calcitonin Gene-Related Peptide, CGRP; Substance P, SP). Overall, these findings support the hypothesis that bTBI causes the activation of microglia and elevation of neuropeptides, which contribute to the development of chronic PTH behaviors.</div></div>","PeriodicalId":52177,"journal":{"name":"Neurobiology of Pain","volume":"17 ","pages":"Article 100178"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11754688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical reflections on medication overuse headache in patients with migraine: An unsolved riddle in nociception
Q2 Medicine Pub Date : 2025-01-01 DOI: 10.1016/j.ynpai.2025.100179
Alberto Chiarugi , Daniela Buonvicino
Migraine chronification very frequently exposes patients to the inevitable risk of excessive symptomatic intake that, in turn, prompts development of medication overuse headache (MOH). The latter further compromises headache severity establishing a vicious cycle of symptomatic intake and relapsing head pain that critically worsens the overall clinical status of patients. A great deal of attention has been focused on MOH pathogenesis, and thanks to preclinical and clinical studies knowledge about this disorder is now remarkably advanced. Still, some open questions remain regarding issues related to the neurobiology and neurochemistry underpinning pain chronification in MOH patients, as well as the remedies capable of interrupting pronociceptive cephalic sensitization and drug overuse. Here, a critical reappraisal of these issues is provided in an attempt to gain deeper insight and promote debate on a pain disorder that still represents a conundrum in the field of nociception.
{"title":"Critical reflections on medication overuse headache in patients with migraine: An unsolved riddle in nociception","authors":"Alberto Chiarugi ,&nbsp;Daniela Buonvicino","doi":"10.1016/j.ynpai.2025.100179","DOIUrl":"10.1016/j.ynpai.2025.100179","url":null,"abstract":"<div><div>Migraine chronification very frequently exposes patients to the inevitable risk of excessive symptomatic intake that, in turn, prompts development of medication overuse headache (MOH). The latter further compromises headache severity establishing a vicious cycle of symptomatic intake and relapsing head pain that critically worsens the overall clinical status of patients. A great deal of attention has been focused on MOH pathogenesis, and thanks to preclinical and clinical studies knowledge about this disorder is now remarkably advanced. Still, some open questions remain regarding issues related to the neurobiology and neurochemistry underpinning pain chronification in MOH patients, as well as the remedies capable of interrupting pronociceptive cephalic sensitization and drug overuse. Here, a critical reappraisal of these issues is provided in an attempt to gain deeper insight and promote debate on a pain disorder that still represents a conundrum in the field of nociception.</div></div>","PeriodicalId":52177,"journal":{"name":"Neurobiology of Pain","volume":"17 ","pages":"Article 100179"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143427655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Targeting Nav1.7 and Nav1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain 用PIKfyve抑制剂靶向Nav1.7和Nav1.8以逆转炎性和神经性疼痛。
Q2 Medicine Pub Date : 2025-01-01 DOI: 10.1016/j.ynpai.2024.100174
Erick J. Rodríguez-Palma , Santiago Loya-Lopez , Sophia M. Min , Aida Calderon-Rivera , Kimberly Gomez , Rajesh Khanna , Alison D. Axtman
PIKfyve (1-phosphatidylinositol 3-phosphate 5-kinase), a lipid kinase, plays an important role in generating phosphatidylinositol (3,5)-bisphosphate (PI(3,5)P2). SGC-PIKFYVE-1, a potent and selective inhibitor of PIKfyve, has been used as a chemical probe to explore pathways dependent on PIKfyve activity. Based on reported changes in membrane dynamics and ion transport in response to PIKfyve inhibition, we hypothesized that pharmacological inhibition of PIKfyve could modulate pain. Acute treatment with SGC-PIKFYVE-1 (10 µM) inhibited voltage-gated sodium currents through the inhibition of Nav1.7 and Nav1.8 channels, without affecting voltage-gated calcium or potassium currents in sensory neurons. Additionally, systemic administration of SGC-PIKFYVE-1 (30 mg/kg) alleviated mechanical and cold sensitivity induced by neuropathic or inflammatory pain in both male and female mice, without causing motor impairments. Although other functions of PIKfyve are well characterized, its role in inhibiting chronic pain has not been fully elucidated. Our study provides proof-of-concept for this alternative approach to pain management. Collectively, these results highlight the inhibitory effects of PIKfyve as a promising avenue for further exploration in chronic pain treatment.
PIKfyve(1-磷脂酰肌醇3-磷酸5激酶)是一种脂质激酶,在生成磷脂酰肌醇(3,5)-二磷酸(PI(3,5)P2)中起重要作用。SGC-PIKFYVE-1是一种有效的选择性PIKfyve抑制剂,已被用作化学探针来探索依赖于PIKfyve活性的途径。根据已报道的PIKfyve抑制后膜动力学和离子转运的变化,我们假设PIKfyve的药物抑制可以调节疼痛。SGC-PIKFYVE-1(10µM)急性治疗通过抑制Nav1.7和Nav1.8通道抑制电压门控钠电流,而不影响感觉神经元的电压门控钙或钾电流。此外,全身给药SGC-PIKFYVE-1 (30 mg/kg)可减轻雄性和雌性小鼠由神经性或炎症性疼痛引起的机械和冷敏感性,而不会引起运动损伤。尽管PIKfyve的其他功能已经被很好地描述,但其在抑制慢性疼痛中的作用尚未完全阐明。我们的研究为这种疼痛管理的替代方法提供了概念证明。总的来说,这些结果突出了PIKfyve的抑制作用,作为进一步探索慢性疼痛治疗的有希望的途径。
{"title":"Targeting Nav1.7 and Nav1.8 with a PIKfyve inhibitor to reverse inflammatory and neuropathic pain","authors":"Erick J. Rodríguez-Palma ,&nbsp;Santiago Loya-Lopez ,&nbsp;Sophia M. Min ,&nbsp;Aida Calderon-Rivera ,&nbsp;Kimberly Gomez ,&nbsp;Rajesh Khanna ,&nbsp;Alison D. Axtman","doi":"10.1016/j.ynpai.2024.100174","DOIUrl":"10.1016/j.ynpai.2024.100174","url":null,"abstract":"<div><div>PIKfyve (1-phosphatidylinositol 3-phosphate 5-kinase), a lipid kinase, plays an important role in generating phosphatidylinositol (3,5)-bisphosphate (PI(3,5)P<sub>2</sub>). SGC-PIKFYVE-1, a potent and selective inhibitor of PIKfyve, has been used as a chemical probe to explore pathways dependent on PIKfyve activity. Based on reported changes in membrane dynamics and ion transport in response to PIKfyve inhibition, we hypothesized that pharmacological inhibition of PIKfyve could modulate pain. Acute treatment with SGC-PIKFYVE-1 (10 µM) inhibited voltage-gated sodium currents through the inhibition of Na<sub>v</sub>1.7 and Na<sub>v</sub>1.8 channels, without affecting voltage-gated calcium or potassium currents in sensory neurons. Additionally, systemic administration of SGC-PIKFYVE-1 (30 mg/kg) alleviated mechanical and cold sensitivity induced by neuropathic or inflammatory pain in both male and female mice, without causing motor impairments. Although other functions of PIKfyve are well characterized, its role in inhibiting chronic pain has not been fully elucidated. Our study provides proof-of-concept for this alternative approach to pain management. Collectively, these results highlight the inhibitory effects of PIKfyve as a promising avenue for further exploration in chronic pain treatment.</div></div>","PeriodicalId":52177,"journal":{"name":"Neurobiology of Pain","volume":"17 ","pages":"Article 100174"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11665415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142886485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence for glial reactivity using positron-emission tomography imaging of translocator Protein-18 kD [TSPO] in both sham and nerve-injured rats in a preclinical model of orofacial neuropathic pain 假手术和神经损伤大鼠口腔面神经病变性疼痛临床前模型中转运蛋白- 18kd [TSPO]的正电子发射断层成像证明神经胶质反应性。
Q2 Medicine Pub Date : 2025-01-01 DOI: 10.1016/j.ynpai.2024.100175
Gaelle M. Emvalomenos , James W.M. Kang , Sabrina Salberg , Crystal Li , Bianca Jupp , Matthew Long , Mohammad B. Haskali , Sunil Kellapatha , OIivia I. Davanzo , Hyunsol Lim , Richelle Mychasiuk , Kevin A. Keay , Luke A. Henderson
Chronic neuropathic pain is a debilitating condition that results from damage to the nervous system. Current treatments are largely ineffective, with limited understanding of the underlying mechanisms hindering development of effective treatments. Preclinical models of neuropathic pain have revealed that non-neural changes are important for the development of neuropathic pain, although these data are derived almost exclusively from post-mortem histological analyses. Although these static snapshots have provided valuable data, they cannot provide insights into non-neural cell changes that could be also assessed in human patients with chronic pain. In this study we used translocator protein 18 kDa (TSPO) PET imaging with [18F]PBR06 to visualise in-vivo, the activity of macrophages and microglia in a rodent preclinical model of trigeminal neuropathic pain. Using chronic constriction injury of the infraorbital nerve (ION-CCI) we compared temporal changes in TSPO binding in male rats, prior to, and up to 28 days after ION-CCI compared with both sham-injured and naïve counterparts. Unexpectedly, we found significant increases in TSPO signal in both ION-CCI and sham-injured rats within the trigeminal ganglion, spinal trigeminal nucleus and paratrigeminal nucleus during the initial phase following surgery and/or nerve injury. This increased TSPO binding returned to control levels by day 28. Qualitative histological appraisal of macrophage accumulation and glial reactivity in both ION-CCI and sham-injured rats indicated macrophage accumulation in the trigeminal ganglion and microglial reactivity in the brainstem trigeminal complex. These findings show, glial changes in the peripheral nerve and brain in both nerve-injured and sham-injured rats in a preclinical model of neuropathic pain which provides a platform for translation into human patients.
慢性神经性疼痛是由神经系统损伤引起的一种使人衰弱的疾病。目前的治疗在很大程度上是无效的,对潜在机制的了解有限,阻碍了有效治疗的发展。神经性疼痛的临床前模型显示,非神经变化对神经性疼痛的发展很重要,尽管这些数据几乎完全来自死后的组织学分析。尽管这些静态快照提供了有价值的数据,但它们不能提供非神经细胞变化的见解,而非神经细胞变化也可以在人类慢性疼痛患者中进行评估。在这项研究中,我们使用转运蛋白18 kDa (TSPO) PET成像与[18F]PBR06来观察三叉神经性疼痛啮齿动物临床前模型中巨噬细胞和小胶质细胞的活体活性。利用慢性眶下神经收缩损伤(ION-CCI),我们比较了雄性大鼠在ION-CCI之前和之后28天TSPO结合的时间变化,与假损伤和naïve对照相比。出乎意料的是,我们发现在手术和/或神经损伤后的初始阶段,离子- cci和假损伤大鼠三叉神经节、三叉神经脊髓核和叉旁核内的TSPO信号显著增加。这种增加的TSPO结合在第28天恢复到对照水平。对离子- cci和假损伤大鼠巨噬细胞积累和神经胶质反应性的定性组织学评价表明,三叉神经节巨噬细胞积累和脑干三叉神经复合体小胶质反应性。这些发现表明,在神经性疼痛的临床前模型中,神经损伤和假损伤大鼠的周围神经和大脑的胶质细胞变化为转化为人类患者提供了平台。
{"title":"Evidence for glial reactivity using positron-emission tomography imaging of translocator Protein-18 kD [TSPO] in both sham and nerve-injured rats in a preclinical model of orofacial neuropathic pain","authors":"Gaelle M. Emvalomenos ,&nbsp;James W.M. Kang ,&nbsp;Sabrina Salberg ,&nbsp;Crystal Li ,&nbsp;Bianca Jupp ,&nbsp;Matthew Long ,&nbsp;Mohammad B. Haskali ,&nbsp;Sunil Kellapatha ,&nbsp;OIivia I. Davanzo ,&nbsp;Hyunsol Lim ,&nbsp;Richelle Mychasiuk ,&nbsp;Kevin A. Keay ,&nbsp;Luke A. Henderson","doi":"10.1016/j.ynpai.2024.100175","DOIUrl":"10.1016/j.ynpai.2024.100175","url":null,"abstract":"<div><div>Chronic neuropathic pain is a debilitating condition that results from damage to the nervous system. Current treatments are largely ineffective, with limited understanding of the underlying mechanisms hindering development of effective treatments. Preclinical models of neuropathic pain have revealed that non-neural changes are important for the development of neuropathic pain, although these data are derived almost exclusively from post-mortem histological analyses. Although these static snapshots have provided valuable data, they cannot provide insights into non-neural cell changes that could be also assessed in human patients with chronic pain. In this study we used translocator protein 18 kDa (TSPO) PET imaging with [<sup>18</sup>F]PBR06 to visualise in-vivo, the activity of macrophages and microglia in a rodent preclinical model of trigeminal neuropathic pain. Using chronic constriction injury of the infraorbital nerve (ION-CCI) we compared temporal changes in TSPO binding in male rats, prior to, and up to 28 days after ION-CCI compared with both sham-injured and naïve counterparts. Unexpectedly, we found significant increases in TSPO signal in both ION-CCI and sham-injured rats within the trigeminal ganglion, spinal trigeminal nucleus and paratrigeminal nucleus during the initial phase following surgery and/or nerve injury. This increased TSPO binding returned to control levels by day 28. Qualitative histological appraisal of macrophage accumulation and glial reactivity in both ION-CCI and sham-injured rats indicated macrophage accumulation in the trigeminal ganglion and microglial reactivity in the brainstem trigeminal complex. These findings show, glial changes in the peripheral nerve and brain in both nerve-injured and sham-injured rats in a preclinical model of neuropathic pain which provides a platform for translation into human patients.</div></div>","PeriodicalId":52177,"journal":{"name":"Neurobiology of Pain","volume":"17 ","pages":"Article 100175"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11699482/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142933485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Keratinocyte-derived extracellular vesicles in painful diabetic neuropathy 疼痛性糖尿病神经病变中角质细胞来源的细胞外囊泡。
Q2 Medicine Pub Date : 2025-01-01 DOI: 10.1016/j.ynpai.2024.100176
James Coy-Dibley , Nirupa D. Jayaraj , Dongjun Ren , Paola Pacifico , Abdelhak Belmadani , Yi-Zhi Wang , Kamil K. Gebis , Jeffrey N. Savas , Amy S. Paller , Richard J. Miller , Daniela M. Menichella
Painful diabetic neuropathy (PDN) is a challenging complication of diabetes with patients experiencing a painful and burning sensation in their extremities. Existing treatments provide limited relief without addressing the underlying mechanisms of the disease. PDN involves the gradual degeneration of nerve fibers in the skin. Keratinocytes, the most abundant epidermal cell type, are closely positioned to cutaneous nerve terminals, suggesting the possibility of bi-directional communication. Extracellular vesicles are lipid-bilayer encapsulated nanovesicles released from many cell types that mediate cell to cell communication. The role of keratinocyte-derived extracellular vesicles (KDEVs) in influencing signaling between the skin and cutaneous nerve terminals and their contribution to the genesis of PDN has not been explored. In this study, we characterized KDEVs in a well-established high-fat diet mouse model of PDN using primary adult mouse keratinocyte cultures. We obtained highly enriched KDEVs through size-exclusion chromatography and then analyzed their molecular cargo using proteomic analysis and small RNA sequencing. We found significant differences in the protein and microRNA content of high-fat diet KDEVs compared to KDEVs obtained from control mice on a regular diet, including pathways involved in axon guidance and synaptic transmission. Additionally, using an in vivo conditional extracellular vesicle reporter mouse model, we demonstrated that epidermal-originating GFP-tagged KDEVs are retrogradely trafficked into the dorsal root ganglion (DRG) neuron cell bodies. This study presents the first comprehensive isolation and molecular characterization of the KDEV protein and microRNA cargo in RD and HFD mice. Our findings suggest a potential novel communication pathway between keratinocytes and DRG neurons in the skin, which could have implications for PDN.
疼痛性糖尿病神经病变(PDN)是一种具有挑战性的糖尿病并发症,患者在其四肢经历疼痛和烧灼感。现有的治疗方法提供有限的缓解,没有解决疾病的潜在机制。PDN涉及皮肤神经纤维的逐渐退化。角化细胞是最丰富的表皮细胞类型,靠近皮神经末梢,提示可能存在双向通讯。细胞外囊泡是由多种细胞释放的脂质双分子层包裹的纳米囊泡,介导细胞间的通讯。角化细胞来源的细胞外囊泡(KDEVs)在影响皮肤和皮神经末梢之间的信号传导中的作用及其对PDN发生的贡献尚未被探索。在这项研究中,我们利用原代成年小鼠角质细胞培养物,在成熟的高脂肪饮食小鼠PDN模型中表征了KDEVs。我们通过尺寸排除层析获得高富集的KDEVs,然后使用蛋白质组学分析和小RNA测序对其分子货物进行分析。我们发现,与常规饮食的对照组小鼠相比,高脂肪饮食的KDEVs的蛋白质和microRNA含量存在显著差异,包括参与轴突引导和突触传递的途径。此外,使用体内条件细胞外囊泡报告小鼠模型,我们证明表皮源性gfp标记的KDEVs可逆行转运到背根神经节(DRG)神经元细胞体中。本研究首次对RD和HFD小鼠的KDEV蛋白和microRNA货物进行了全面的分离和分子表征。我们的研究结果表明,皮肤中角质形成细胞和DRG神经元之间可能存在一种新的通信途径,这可能对PDN有影响。
{"title":"Keratinocyte-derived extracellular vesicles in painful diabetic neuropathy","authors":"James Coy-Dibley ,&nbsp;Nirupa D. Jayaraj ,&nbsp;Dongjun Ren ,&nbsp;Paola Pacifico ,&nbsp;Abdelhak Belmadani ,&nbsp;Yi-Zhi Wang ,&nbsp;Kamil K. Gebis ,&nbsp;Jeffrey N. Savas ,&nbsp;Amy S. Paller ,&nbsp;Richard J. Miller ,&nbsp;Daniela M. Menichella","doi":"10.1016/j.ynpai.2024.100176","DOIUrl":"10.1016/j.ynpai.2024.100176","url":null,"abstract":"<div><div>Painful diabetic neuropathy (PDN) is a challenging complication of diabetes with patients experiencing a painful and burning sensation in their extremities. Existing treatments provide limited relief without addressing the underlying mechanisms of the disease. PDN involves the gradual degeneration of nerve fibers in the skin. Keratinocytes, the most abundant epidermal cell type, are closely positioned to cutaneous nerve terminals, suggesting the possibility of bi-directional communication. Extracellular vesicles are lipid-bilayer encapsulated nanovesicles released from many cell types that mediate cell to cell communication. The role of keratinocyte-derived extracellular vesicles (KDEVs) in influencing signaling between the skin and cutaneous nerve terminals and their contribution to the genesis of PDN has not been explored. In this study, we characterized KDEVs in a well-established high-fat diet mouse model of PDN using primary adult mouse keratinocyte cultures. We obtained highly enriched KDEVs through size-exclusion chromatography and then analyzed their molecular cargo using proteomic analysis and small RNA sequencing. We found significant differences in the protein and microRNA content of high-fat diet KDEVs compared to KDEVs obtained from control mice on a regular diet, including pathways involved in axon guidance and synaptic transmission. Additionally, using an <em>in vivo</em> conditional extracellular vesicle reporter mouse model, we demonstrated that epidermal-originating GFP-tagged KDEVs are retrogradely trafficked into the dorsal root ganglion (DRG) neuron cell bodies. This study presents the first comprehensive isolation and molecular characterization of the KDEV protein and microRNA cargo in RD and HFD mice. Our findings suggest a potential novel communication pathway between keratinocytes and DRG neurons in the skin, which could have implications for PDN.</div></div>","PeriodicalId":52177,"journal":{"name":"Neurobiology of Pain","volume":"17 ","pages":"Article 100176"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731614/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuronal activation patterns during self-referential pain imagination 自我参照疼痛想象过程中的神经元激活模式
Q2 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.ynpai.2024.100158
Annabel Vetterlein , Thomas Plieger , Merlin Monzel , Svea A. Hogeterp , Lilli Wagner , Thomas Grünhage , Andrea Felten , Peter Trautner , Jana Karneboge , Martin Reuter

In clinical assessments and pain therapy, patients are asked to imagine themselves in pain. However, the underlying neuronal processes remain poorly understood. Prior research has focused on empathy for pain or reported small sample sizes. Thus, the present study aimed to promote the neurobiological understanding of self-referential pain imagination. We hypothesised to find activation contrasts (pain vs. no pain) across pain-related areas and expected two of the most prominent predictors of chronic pain, pain sensitivity (PS) and locus of control (LoC), to be moderators.

In an fMRI study, N = 82 participants completed a pain imagination task, in which they were asked to imagine themselves in painful and non-painful situations presented in the form of pictures and texts. After each trial, they were instructed to give painfulness ratings. As a laboratory measure of PS, electrical pain thresholds were assessed. A questionnaire was completed to measure LoC.

Across presentation modes we found activity contrasts in previously pain-related regions, such as the prefrontal, supplementary motor, primary motor, somatosensory and posterior parietal cortices, and the cerebellum. We found positive associations of PS and external LoC with painfulness ratings, and a negative correlation between PS and internal LoC. Despite our hypotheses, neither PS nor internal LoC were significant predictors of the BOLD-signal contrasts.

Though future studies are needed to draw further conclusions, our results provide preliminary evidence of a potential neuronal imagination-perception overlap in pain.

在临床评估和疼痛治疗中,患者会被要求想象自己处于疼痛之中。然而,人们对其背后的神经元过程仍然知之甚少。之前的研究主要集中在对疼痛的移情方面,或者报告的样本量较小。因此,本研究旨在促进对自我疼痛想象的神经生物学理解。我们假设会发现疼痛相关区域的激活对比(疼痛与无痛),并预期慢性疼痛最主要的两个预测因素--疼痛敏感性(PS)和控制点(LoC)会成为调节因素。
{"title":"Neuronal activation patterns during self-referential pain imagination","authors":"Annabel Vetterlein ,&nbsp;Thomas Plieger ,&nbsp;Merlin Monzel ,&nbsp;Svea A. Hogeterp ,&nbsp;Lilli Wagner ,&nbsp;Thomas Grünhage ,&nbsp;Andrea Felten ,&nbsp;Peter Trautner ,&nbsp;Jana Karneboge ,&nbsp;Martin Reuter","doi":"10.1016/j.ynpai.2024.100158","DOIUrl":"10.1016/j.ynpai.2024.100158","url":null,"abstract":"<div><p>In clinical assessments and pain therapy, patients are asked to imagine themselves in pain. However, the underlying neuronal processes remain poorly understood. Prior research has focused on empathy for pain or reported small sample sizes. Thus, the present study aimed to promote the neurobiological understanding of self-referential pain imagination. We hypothesised to find activation contrasts (pain vs. no pain) across pain-related areas and expected two of the most prominent predictors of chronic pain, pain sensitivity (PS) and locus of control (LoC), to be moderators.</p><p>In an fMRI study, <em>N</em> = 82 participants completed a pain imagination task, in which they were asked to imagine themselves in painful and non-painful situations presented in the form of pictures and texts. After each trial, they were instructed to give painfulness ratings. As a laboratory measure of PS, electrical pain thresholds were assessed. A questionnaire was completed to measure LoC.</p><p>Across presentation modes we found activity contrasts in previously pain-related regions, such as the prefrontal, supplementary motor, primary motor, somatosensory and posterior parietal cortices, and the cerebellum. We found positive associations of PS and external LoC with painfulness ratings, and a negative correlation between PS and internal LoC. Despite our hypotheses, neither PS nor internal LoC were significant predictors of the BOLD-signal contrasts.</p><p>Though future studies are needed to draw further conclusions, our results provide preliminary evidence of a potential neuronal imagination-perception overlap in pain.</p></div>","PeriodicalId":52177,"journal":{"name":"Neurobiology of Pain","volume":"16 ","pages":"Article 100158"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452073X24000096/pdfft?md5=8a9c2603322477b07469a22e7aeb5eea&pid=1-s2.0-S2452073X24000096-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141784323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel therapies for cancer-induced bone pain 治疗癌症引起的骨痛的新疗法
Q2 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.ynpai.2024.100167
Rayan Haroun , Samuel J. Gossage , Federico Iseppon , Alexander Fudge , Sara Caxaria , Manuel Arcangeletti , Charlotte Leese , Bazbek Davletov , James J. Cox , Shafaq Sikandar , Fraser Welsh , Iain P. Chessell , John N. Wood
Cancer pain is a growing problem, especially with the substantial increase in cancer survival. Reports indicate that bone metastasis, whose primary symptom is bone pain, occurs in 65–75% of patients with advanced breast or prostate cancer. We optimized a preclinical in vivo model of cancer-induced bone pain (CIBP) involving the injection of Lewis Lung Carcinoma cells into the intramedullary space of the femur of C57BL/6 mice or transgenic mice on a C57BL/6 background. Mice gradually reduce the use of the affected limb, leading to altered weight bearing. Symptoms of secondary cutaneous heat sensitivity also manifest themselves. Following optimization, three potential analgesic treatments were assessed; 1) single ion channel targets (targeting the voltage-gated sodium channels NaV1.7, NaV1.8, or acid-sensing ion channels), 2) silencing µ-opioid receptor-expressing neurons by modified botulinum compounds, and 3) targeting two inflammatory mediators simultaneously (nerve growth factor (NGF) and tumor necrosis factor (TNF)). Unlike global NaV1.8 knockout mice which do not show any reduction in CIBP-related behavior, embryonic conditional NaV1.7 knockout mice in sensory neurons exhibit a mild reduction in CIBP-linked behavior. Modified botulinum compounds also failed to cause a detectable analgesic effect. In contrast, inhibition of NGF and/or TNF resulted in a significant reduction in CIBP-driven weight-bearing alterations and prevented the development of secondary cutaneous heat hyperalgesia. Our results support the inhibition of these inflammatory mediators, and more strongly their dual inhibition to treat CIBP, given the superiority of combination therapies in extending the time needed to reach limb use score zero in our CIBP model.
癌症疼痛是一个日益严重的问题,尤其是随着癌症存活率的大幅提高。有报告显示,65%-75%的晚期乳腺癌或前列腺癌患者会出现骨转移,其主要症状是骨痛。我们优化了癌症诱导骨痛(CIBP)的临床前体内模型,将路易斯肺癌细胞注射到 C57BL/6 小鼠或 C57BL/6 背景的转基因小鼠的股骨髓内间隙。小鼠会逐渐减少患肢的使用,导致负重能力改变。继发性皮肤热敏感症状也会显现出来。经过优化后,评估了三种潜在的镇痛疗法:1)单一离子通道靶点(靶向电压门控钠通道 NaV1.7、NaV1.8 或酸感应离子通道);2)通过改良肉毒杆菌化合物沉默表达μ-阿片受体的神经元;3)同时靶向两种炎症介质(神经生长因子(NGF)和肿瘤坏死因子(TNF))。全基因敲除 NaV1.8 小鼠的 CIBP 相关行为并未减少,而胚胎条件性 NaV1.7 感觉神经元敲除小鼠的 CIBP 相关行为则轻微减少。改良肉毒杆菌化合物也未能产生可检测到的镇痛效果。相反,抑制 NGF 和/或 TNF 可显著减少 CIBP 驱动的负重改变,并防止继发性皮肤热痛。我们的研究结果支持抑制这些炎症介质,而且鉴于联合疗法在延长我们的 CIBP 模型中达到肢体使用零分所需的时间方面具有优势,我们更支持通过双重抑制来治疗 CIBP。
{"title":"Novel therapies for cancer-induced bone pain","authors":"Rayan Haroun ,&nbsp;Samuel J. Gossage ,&nbsp;Federico Iseppon ,&nbsp;Alexander Fudge ,&nbsp;Sara Caxaria ,&nbsp;Manuel Arcangeletti ,&nbsp;Charlotte Leese ,&nbsp;Bazbek Davletov ,&nbsp;James J. Cox ,&nbsp;Shafaq Sikandar ,&nbsp;Fraser Welsh ,&nbsp;Iain P. Chessell ,&nbsp;John N. Wood","doi":"10.1016/j.ynpai.2024.100167","DOIUrl":"10.1016/j.ynpai.2024.100167","url":null,"abstract":"<div><div>Cancer pain is a growing problem, especially with the substantial increase in cancer survival. Reports indicate that bone metastasis, whose primary symptom is bone pain, occurs in 65–75% of patients with advanced breast or prostate cancer. We optimized a preclinical <em>in vivo</em> model of cancer-induced bone pain (CIBP) involving the injection of Lewis Lung Carcinoma cells into the intramedullary space of the femur of C57BL/6 mice or transgenic mice on a C57BL/6 background. Mice gradually reduce the use of the affected limb, leading to altered weight bearing. Symptoms of secondary cutaneous heat sensitivity also manifest themselves. Following optimization, three potential analgesic treatments were assessed; 1) single ion channel targets (targeting the voltage-gated sodium channels Na<sub>V</sub>1.7, Na<sub>V</sub>1.8, or acid-sensing ion channels), 2) silencing µ-opioid receptor-expressing neurons by modified botulinum compounds, and 3) targeting two inflammatory mediators simultaneously (nerve growth factor (NGF) and tumor necrosis factor (TNF)). Unlike global Na<sub>V</sub>1.8 knockout mice which do not show any reduction in CIBP-related behavior, embryonic conditional Na<sub>V</sub>1.7 knockout mice in sensory neurons exhibit a mild reduction in CIBP-linked behavior. Modified botulinum compounds also failed to cause a detectable analgesic effect. In contrast, inhibition of NGF and/or TNF resulted in a significant reduction in CIBP-driven weight-bearing alterations and prevented the development of secondary cutaneous heat hyperalgesia. Our results support the inhibition of these inflammatory mediators, and more strongly their dual inhibition to treat CIBP, given the superiority of combination therapies in extending the time needed to reach limb use score zero in our CIBP model.</div></div>","PeriodicalId":52177,"journal":{"name":"Neurobiology of Pain","volume":"16 ","pages":"Article 100167"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142357105","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
B-cell and plasma cell activation in a mouse model of chronic muscle pain 慢性肌肉疼痛小鼠模型中的 B 细胞和浆细胞活化
Q2 Medicine Pub Date : 2024-07-01 DOI: 10.1016/j.ynpai.2024.100169
Melissa E. Lenert , Audrey R. Green , Ericka N. Merriwether , Michael D. Burton
Fibromyalgia (FM) is a complex chronic musculoskeletal pain disorder with an elusive pathogenesis, with a strong implication of immune interactions. We recently found that IL-5 and the adaptive immune system mediates pain outcomes in fibromyalgia (FM) patients and preclinical models of FM-like chronic widespread pain (CWP). However, there is an active debate if FM/CWP has an autoimmune etiology. Preclinical models of CWP utilize a repeated insult paradigm, which resembles a primary, then secondary response similarly observed in the antibody response, in which the subsequent event causes a potentiated pain response. Recent translational studies have implicated immunoglobulins (Ig) and B-cells in FM/CWP pathophysiology. To understand if these are involved in preclinical models of CWP, we performed comprehensive B-cell phenotyping in the bone marrow, circulation, and popliteal (draining) lymph nodes in the two-hit acidic saline model of CWP. We found increased MHC class II-expressing B-cells in peripheral blood, increased activated plasma cells in peripheral blood, and increased memory B-cells in the bone marrow. Interestingly, acidic pH (4.0) injected mice have reduced levels of IgG1, independent of treatment with IL-5. We have demonstrated that the acidic saline model of CWP induces T-cell mediated activation of B-cells, increased active plasma cells, and increased memory B-cells in female mice.
纤维肌痛(FM)是一种复杂的慢性肌肉骨骼疼痛疾病,其发病机制难以捉摸,与免疫相互作用有密切关系。我们最近发现,IL-5 和适应性免疫系统介导了纤维肌痛(FM)患者和 FM 类慢性广泛性疼痛(CWP)临床前模型的疼痛结果。然而,FM/CWP 是否具有自身免疫病因学还存在激烈的争论。慢性广泛性疼痛的临床前模型采用了一种重复侮辱范式,这种范式类似于抗体反应中观察到的先原发后继反应,在这种范式中,随后发生的事件会导致疼痛反应增强。最近的转化研究表明,免疫球蛋白(Ig)和 B 细胞与 FM/CWP 病理生理学有关。为了了解临床前 CWP 模型是否与这些因素有关,我们在两击酸性盐水 CWP 模型中对骨髓、血液循环和腘窝(引流)淋巴结进行了全面的 B 细胞表型分析。我们发现外周血中表达 MHC II 类的 B 细胞增多,外周血中活化浆细胞增多,骨髓中记忆性 B 细胞增多。有趣的是,注射酸性 pH 值(4.0)的小鼠 IgG1 水平降低,与 IL-5 治疗无关。我们已经证明,CWP 的酸性生理盐水模型可诱导 T 细胞介导的 B 细胞活化、活性浆细胞增加以及雌性小鼠记忆性 B 细胞增加。
{"title":"B-cell and plasma cell activation in a mouse model of chronic muscle pain","authors":"Melissa E. Lenert ,&nbsp;Audrey R. Green ,&nbsp;Ericka N. Merriwether ,&nbsp;Michael D. Burton","doi":"10.1016/j.ynpai.2024.100169","DOIUrl":"10.1016/j.ynpai.2024.100169","url":null,"abstract":"<div><div>Fibromyalgia (FM) is a complex chronic musculoskeletal pain disorder with an elusive pathogenesis, with a strong implication of immune interactions. We recently found that IL-5 and the adaptive immune system mediates pain outcomes in fibromyalgia (FM) patients and preclinical models of FM-like chronic widespread pain (CWP). However, there is an active debate if FM/CWP has an autoimmune etiology. Preclinical models of CWP utilize a repeated insult paradigm, which resembles a primary, then secondary response similarly observed in the antibody response, in which the subsequent event causes a potentiated pain response. Recent translational studies have implicated immunoglobulins (Ig) and B-cells in FM/CWP pathophysiology. To understand if these are involved in preclinical models of CWP, we performed comprehensive B-cell phenotyping in the bone marrow, circulation, and popliteal (draining) lymph nodes in the two-hit acidic saline model of CWP. We found increased MHC class II-expressing B-cells in peripheral blood, increased activated plasma cells in peripheral blood, and increased memory B-cells in the bone marrow. Interestingly, acidic pH (4.0) injected mice have reduced levels of IgG1, independent of treatment with IL-5. We have demonstrated that the acidic saline model of CWP induces T-cell mediated activation of B-cells, increased active plasma cells, and increased memory B-cells in female mice.</div></div>","PeriodicalId":52177,"journal":{"name":"Neurobiology of Pain","volume":"16 ","pages":"Article 100169"},"PeriodicalIF":0.0,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142533681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Neurobiology of Pain
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1